ABMIUM was built to remove one of the biggest silent killers of research productivity: reagent uncertainty.

When a reagent fails, the real cost is repeat work, delayed decisions, burned budgets, and avoidable waste across plastics, solvents, cold chain logistics, and energy intensive storage. This is not just a technical problem. It is a sustainability and responsibility problem hiding in plain sight.

My training in corporate responsibility and sustainability shaped a clear conviction: the next era of life science will be won by teams that make performance proof normal, not optional. Social justice matters here too, because labs with tighter budgets are punished hardest by trial and error.

ABMIUM is building an independent performance intelligence layer for RUO reagents. We map products to real use cases, capture the conditions that decide success, and publish decision grade Evidence Packs that make outcomes comparable, defensible, and easy to act on.

This work also creates a practical ESG reporting pathway. By reducing avoidable repeats, ABMIUM supports measurable impact across:

Environment: reduced consumables and packaging waste, fewer shipments and cold chain movements, lower energy demand from storage and repeat processing.

Social: more equitable access to reliable research tools, less wasted grant spend, faster progress for teams under tight constraints.

Governance: clear evidence standards, transparent documentation, and decision trails that strengthen accountability across the value chain.

We are not in a trading phase today. ABMIUM is in build and pilot mode, focused on evidence standards, validation workflows, and partner alignment. No orders are accepted through this website.

For researchers, this means fewer reruns and faster progress. For collaborators, this means higher trust, clearer workflow guidance, and stronger adoption, powered by evidence that reflects real bench conditions.

Veron Duberry
Founder, ABMIUM